92 related articles for article (PubMed ID: 1904563)
1. Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis.
Maimone D; Reder AT
Neurology; 1991 Jun; 41(6):851-4. PubMed ID: 1904563
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
J Neuroimmunol; 1990 Jul; 28(2):97-109. PubMed ID: 2113934
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.
Hintzen RQ; van Lier RA; Kuijpers KC; Baars PA; Schaasberg W; Lucas CJ; Polman CH
J Neuroimmunol; 1991 Dec; 35(1-3):211-7. PubMed ID: 1659587
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.
Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V
Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901
[TBL] [Abstract][Full Text] [Related]
6. Shedding of the soluble form of the CD8 complex by CD8+/HLA-DR+ cells in HIV-1-infected patients.
Agostini C; Pizzolo G; Zambello R; Trentin L; Siviero F; Vinante F; Morosato L; Francavilla E; Cadrobbi P; Semenzato G
AIDS; 1991 Jul; 5(7):813-9. PubMed ID: 1832545
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease.
Nishanian P; Hofmann B; Wang Y; Jackson AL; Detels R; Fahey JL
AIDS; 1991 Jul; 5(7):805-12. PubMed ID: 1909873
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of soluble CD8 molecule in patients with lymphatic filariasis.
Lal RB; Ramzy RM; Gad AA
Immunol Lett; 1990 Oct; 26(1):85-8. PubMed ID: 2148926
[TBL] [Abstract][Full Text] [Related]
9. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Mehta SP; Sobczyk W; Coyle PK; Sersen EA; Wisniewski HM
Clin Immunol Immunopathol; 1992 Oct; 65(1):53-9. PubMed ID: 1382909
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
J Neuroimmunol; 1991 Dec; 35(1-3):285-93. PubMed ID: 1955570
[TBL] [Abstract][Full Text] [Related]
12. Elevated soluble CD8 in the synovial fluid from patients with rheumatoid arthritis.
Carpenter AB; Eisenbeis CH; Carrabis S; Brown MC; Ip SH
J Clin Lab Anal; 1990; 4(5):337-41. PubMed ID: 2121924
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses.
Kim HS; Degiannis D; Raskova J; Raska K
Clin Immunol Immunopathol; 1991 Jul; 60(1):27-39. PubMed ID: 1904329
[TBL] [Abstract][Full Text] [Related]
15. Phenotype analysis of unstimulated lymphocytes and anti-CD3-stimulated proliferating T-cells from cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and other neurological diseases.
Dufour A; Salmaggi A; Eoli M; La Mantia L; Milanese C; Nespolo A
Int J Neurosci; 1993 Dec; 73(3-4):277-85. PubMed ID: 7513316
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
Maxeiner HG; Rojewski MT; Schmitt A; Tumani H; Bechter K; Schmitt M
Brain Behav Immun; 2009 Jan; 23(1):134-42. PubMed ID: 18771722
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
[TBL] [Abstract][Full Text] [Related]
18. Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system.
Oreja-Guevara C; Sindern E; Raulf-Heimsoth M; Malin JP
Acta Neurol Scand; 1998 Nov; 98(5):310-3. PubMed ID: 9858099
[TBL] [Abstract][Full Text] [Related]
19. Increased serum CD8 soluble antigen level is associated with blood lymphocyte abnormalities and other established indicators of a poor prognosis in adult Hodgkin's disease.
Grimfors G; Andersson B; Tullgren O; Giscombe R; Holm G; Johansson B; Björkholm M
Br J Haematol; 1992 Feb; 80(2):166-71. PubMed ID: 1550771
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.
McMillan SA; McDonnell GV; Douglas JP; Droogan AG; Hawkins SA
Neurology; 1998 Oct; 51(4):1156-60. PubMed ID: 9781547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
